Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 15, 2023
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
Greg Harrison Downgraded (BEAM) to Hold and Held Target at $35 on, Dec 15th, 2023
Greg Harrison of B of A Securities, Downgraded "Beam Therapeutics Inc." (BEAM) to Hold and Held Target at $35 on, Dec 15th, 2023.
Greg has made no other calls on BEAM in the last 4 months.
There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 1 agrees with Greg's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $30 on, Friday, December 8th, 2023
This is the rating of the analyst that currently disagrees with Greg
- Rick Bienkowski of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $32 on, Tuesday, October 17th, 2023
